BamSEC and AlphaSense Join Forces
Learn More

Alto Neuroscience Inc. – Indentures

NYSE: ANRO    
Share price (6/3/26): $18.85    
Market cap (6/3/26): $662 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5
from 10-K 7 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 12 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 16 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.5
from 10-K 7 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.10
from S-3 18 pages Alto Neuroscience, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Alto Neuroscience, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.9
from S-3 20 pages Alto Neuroscience, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Alto Neuroscience, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.8
from S-3 20 pages Alto Neuroscience, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Alto Neuroscience, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3 55 pages Alto Neuroscience, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.2
from 8-K 9 pages Warrant to Purchase Stock
12/34/56
EX-4.1
from 8-K 10 pages Amended and Restated Warrant to Purchase Stock
12/34/56
EX-4.4
from 10-K 5 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.3
from S-1 14 pages Warrant to Purchase Preferred Stock
12/34/56
EX-4.2
from S-1 55 pages Alto Neuroscience, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.3
from DRS 14 pages Warrant to Purchase Preferred Stock
12/34/56
EX-4.2
from DRS 55 pages Alto Neuroscience, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56